Compare KBSX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KBSX | DRIO |
|---|---|---|
| Founded | 1976 | 2011 |
| Country | Taiwan | United States |
| Employees | 394 | 165 |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 60.6M |
| IPO Year | N/A | 2013 |
| Metric | KBSX | DRIO |
|---|---|---|
| Price | $1.43 | $8.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 102.1K | 7.6K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | $18.65 | $20.27 |
| Revenue Next Year | $16.31 | $47.58 |
| P/E Ratio | ★ N/A | $6.64 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.04 | $0.38 |
| 52 Week High | $2.52 | $17.74 |
| Indicator | KBSX | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 56.11 |
| Support Level | $1.32 | $6.16 |
| Resistance Level | $1.61 | $9.46 |
| Average True Range (ATR) | 0.09 | 0.44 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 75.86 | 72.37 |
FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.